Last week, the U.S. Securities and Exchange Commission announced fraud charges against Robert Tye Cournoyer and two CBD-related companies that he controlled for their alleged misappropriation of investor funds and false and misleading statements to investors. Cournoyer also never told investors that the SEC had previously charged him with fraud, and a court sanctioned him for that…